TC BioPharm (Holdings) PLC (TCBP)
0.662
+0.01
(+2.03%)
USD |
NASDAQ |
Nov 15, 16:00
0.6019
-0.06
(-9.08%)
After-Hours: 20:00
TC BioPharm Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 8.900M |
June 30, 2023 | 9.463M |
Date | Value |
---|---|
March 31, 2023 | 8.848M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.848M
Minimum
Mar 2023
9.463M
Maximum
Jun 2023
9.071M
Average
8.900M
Median
Mar 2024
Research and Development Expense (TTM) Benchmarks
Adaptimmune Therapeutics PLC | 143.17M |
Biodexa Pharmaceuticals PLC | -- |
Verona Pharma PLC | 40.83M |
NuCana PLC | 35.08M |
Autolus Therapeutics PLC | 129.68M |